Author:
Proye P.,Boissier R.,Bastide C.,Lechevallier E.,Baboudjian M.
Reference21 articles.
1. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006
2. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ);Babjuk;Eur Urol,2021
3. Recommandations françaises du Comité de cancérologie de l’AFU–actualisation 2020-2022: tumeurs de la vessie [French ccAFU guidelines - update 2020-2022: bladder cancer];Rouprêt;Prog Urol,2020
4. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System);Panebianco;Eur Urol,2018
5. Time to turn on the blue lights: a systematic review and meta-analysis of photodynamic diagnosis for bladder cancer;Veeratterapillay;Eur Urol Open Sci,2021